Conjugated hyperbilirubinemia in infancy is seen in –
**Question:** Conjugated hyperbilirubinemia in infancy is seen in –
A. Jaundice
B. Hepatitis
C. Hemolysis
D. Gallstones
**Core Concept:** Conjugated hyperbilirubinemia refers to the presence of unconjugated bilirubin, specifically indirect bilirubin, which is the result of conjugation and glucuronidation processes in the liver. In infants, this condition is often due to immature liver function or increased hemolysis.
**Why the Correct Answer is Right:** Conjugated hyperbilirubinemia in infancy is primarily seen in cases of **hemolysis**. Hemolysis leads to the release of unconjugated bilirubin into the bloodstream, which is then transported to the liver for conjugation and glucuronidation before being excreted in the bile. In infants, this process may be incomplete or insufficient, causing elevated indirect bilirubin levels.
**Why Each Wrong Option is Incorrect:**
A. Jaundice: Jaundice is a clinical sign, not a cause of hyperbilirubinemia. It is a yellow discoloration of the skin and mucous membranes due to increased bilirubin levels. However, jaundice itself is not a cause of hyperbilirubinemia but rather a symptom.
B. Hepatitis: Hepatitis is an inflammation of the liver. While hepatitis can lead to impaired liver function, it is not the primary cause of conjugated hyperbilirubinemia in infants. The primary cause in this scenario is hemolysis, leading to increased unconjugated bilirubin production.
C. Gallstones: Gallstones are formed due to cholesterol, calcium bilirubin, or a combination of both, which do not directly explain conjugated hyperbilirubinemia in infants. Hemolysis is the primary cause in this context.
D. Gallstones: Similar to option C, gallstones are unrelated to the pathogenesis of conjugated hyperbilirubinemia in infants. The primary cause is hemolysis, leading to increased unconjugated bilirubin production.
**Clinical Pearl:** In neonates and infants, conjugated hyperbilirubinemia due to hemolysis is a common cause of hyperbilirubinemia, requiring close monitoring and potential treatment, including phototherapy or exchange transfusion, depending on the severity of the condition.